Anti-AGRL4/ ADGRL4/ ELTD1 monoclonal antibody

Anti-AGRL4/ ADGRL4/ ELTD1 antibody for FACS & in-vivo assay

Target products collectionGo to ADGRL4/ADGRL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0400-Ab-1/ GM-Tg-hg-MP0400-Ab-2Anti-Human ADGRL4 monoclonal antibodyHuman
GM-Tg-rg-MP0400-Ab-1/ GM-Tg-rg-MP0400-Ab-2Anti-Rat ADGRL4 monoclonal antibodyRat
GM-Tg-mg-MP0400-Ab-1/ GM-Tg-mg-MP0400-Ab-2Anti-Mouse ADGRL4 monoclonal antibodyMouse
GM-Tg-cynog-MP0400-Ab-1/ GM-Tg-cynog-MP0400-Ab-2Anti-Cynomolgus/ Rhesus macaque ADGRL4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0400-Ab-1/ GM-Tg-felg-MP0400-Ab-2Anti-Feline ADGRL4 monoclonal antibodyFeline
GM-Tg-cang-MP0400-Ab-1/ GM-Tg-cang-MP0400-Ab-2Anti-Canine ADGRL4 monoclonal antibodyCanine
GM-Tg-bovg-MP0400-Ab-1/ GM-Tg-bovg-MP0400-Ab-2Anti-Bovine ADGRL4 monoclonal antibodyBovine
GM-Tg-equg-MP0400-Ab-1/ GM-Tg-equg-MP0400-Ab-2Anti-Equine ADGRL4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0400-Ab-1/ GM-Tg-hg-MP0400-Ab-2; GM-Tg-rg-MP0400-Ab-1/ GM-Tg-rg-MP0400-Ab-2;
GM-Tg-mg-MP0400-Ab-1/ GM-Tg-mg-MP0400-Ab-2; GM-Tg-cynog-MP0400-Ab-1/ GM-Tg-cynog-MP0400-Ab-2;
GM-Tg-felg-MP0400-Ab-1/ GM-Tg-felg-MP0400-Ab-2; GM-Tg-cang-MP0400-Ab-1/ GM-Tg-cang-MP0400-Ab-2;
GM-Tg-bovg-MP0400-Ab-1/ GM-Tg-bovg-MP0400-Ab-2; GM-Tg-equg-MP0400-Ab-1/ GM-Tg-equg-MP0400-Ab-2
Products NameAnti-ADGRL4 monoclonal antibody
Formatmab
Target NameADGRL4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADGRL4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AGRL4/ ADGRL4/ ELTD1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000067human ADGRL4 Lentivirus particle
    ORF Viral VectorpGMLV000067human ADGRL4 Lentivirus plasmid
    ORF Viral VectorpGMLPm004029mouse Adgrl4 Lentivirus plasmid
    ORF Viral VectorvGMLPm004029mouse Adgrl4 Lentivirus particle


    Target information

    Target IDGM-MP0400
    Target NameADGRL4
    Gene ID64123,170757,64124,711589,102152304,101093625,535066,100052983
    Gene Symbol and Synonyms1110033N21Rik,ADGRL4,ELTD1,ETL,ETL1,KPG_003
    Uniprot AccessionQ9HBW9,Q9ESC1
    Uniprot Entry NameAGRL4_HUMAN,AGRL4_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162618
    Target ClassificationN/A

    The target: ADGRL4, gene name: ADGRL4, also named as ELTD1, ETL, KPG_003. Predicted to enable G protein-coupled receptor activity. Predicted to be involved in adenylate cyclase-activating G protein-coupled receptor signaling pathway. Predicted to be located in cytoplasmic vesicle and plasma membrane. Predicted to be integral component of plasma membrane. Biomarker of glioblastoma and hypertrophic cardiomyopathy. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.